The AP-2gamma transcription factor is upregulated in advanced-stage ovarian carcinoma. (Q54777583)

3 June 2018

title

The AP-2gamma transcription factor is upregulated in advanced-stage ovarian carcinoma. (English)

1 reference

3 June 2018

6

Claes G Tropé

1 reference

3 June 2018

Anne C Staff

2

object named as

Anne Cathrine Staff

1 reference

3 June 2018

author name string

Elin Ødegaard

1

1 reference

3 June 2018

Janne Kaern

3

1 reference

3 June 2018

Vivi Ann Flørenes

4

1 reference

3 June 2018

Juri Kopolovic

5

1 reference

3 June 2018

Vera M Abeler

7

1 reference

3 June 2018

Reuven Reich

8

1 reference

3 June 2018

Ben Davidson

9

1 reference

3 June 2018

language of work or name

English

0 references

publication date

10 October 2005

1 reference

3 June 2018

published in

Gynecologic Oncology

1 reference

3 June 2018

volume

100

1 reference

3 June 2018

issue

3

1 reference

3 June 2018

page(s)

462-468

1 reference

3 June 2018

cites work

Cancer statistics, 2004

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

Long-term survival and patterns of care in women with ovarian tumors of low malignant potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

Surgical staging in patients with ovarian tumors of low malignant potential

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

Subclassification of serous borderline tumors of the ovary into benign and malignant types. A clinicopathologic study of 65 advanced stage cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

Ovarian serous borderline tumors: the citadel defended

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

Chromosomal mapping of the human and mouse homologues of two new members of the AP-2 family of transcription factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

Transcription factor AP-2 essential for cranial closure and craniofacial development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

Transcription factor AP-2gamma is a developmentally regulated marker of testicular carcinoma in situ and germ cell tumors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

Activator protein-2gamma (AP-2gamma) expression is specifically induced by oestrogens through binding of the oestrogen receptor to a canonical element within the 5'-untranslated region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

Regulatory roles of AP-2 transcription factors in vertebrate development, apoptosis and cell-cycle control

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

Regulation of gene expression in melanoma: new approaches for treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

Role of AP-2 in tumor growth and metastasis of human melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

Transcriptional regulation of metastasis-related genes in human melanoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

Characterization of the human activator protein-2gamma (AP-2gamma) gene: control of expression by Sp1/Sp3 in breast tumour cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

The human transcription factor activation protein-2 gamma (AP-2gamma): gene structure, promoter, and expression in mammary carcinoma cell lines.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

Distinct spatial expression patterns of AP-2alpha and AP-2gamma in non-neoplastic human breast and breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

Differential expression of activator protein-2 isoforms in renal cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

Expression of transcription factor AP-2 in colorectal adenomas and adenocarcinomas; comparison of immunohistochemistry and in situ hybridisation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

Downregulation of transcription factor AP-2 predicts poor survival in stage I cutaneous malignant melanoma.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

Immunohistochemical analysis reveals a tumour suppressor-like role for the transcription factor AP-2 in invasive breast cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

Expression of c-ABL, c-KIT, and platelet-derived growth factor receptor-beta in ovarian serous carcinoma and normal ovarian surface epithelium

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

AP2alpha and AP2gamma: a comparison of binding site specificity and trans-activation of the estrogen receptor promoter and single site promoter constructs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YGYNO.2005.09.022

10.1016/J.YGYNO.2005.09.022

7 January 2021

Identifiers

DOI

1 reference

3 June 2018

1 reference

3 June 2018